University of South Australia Identifies Genetic Drivers of Long COVID in Australia

University of South Australia Identifies Genetic Drivers of Long COVID in Australia

Background: The Growing Burden of Long COVID

Since the onset of the COVID‑19 pandemic, more than 400 million people worldwide have reported lingering symptoms that extend beyond the acute phase of infection. In Australia alone, the condition has become a public health priority, with estimates suggesting that a significant portion of the population continues to experience fatigue, breathlessness, cardiovascular complications, and cognitive difficulties months after recovery. The lack of a single diagnostic marker has made it difficult for clinicians to predict who will develop long‑term complications.

Research Approach: Integrating Multi‑Omics Data

University of South Australia scientists led a comprehensive analysis that combined genomic, proteomic, metabolomic, transcriptomic, and epigenomic data from over 100 international studies. By applying advanced bioinformatics and machine‑learning techniques, the team identified 32 genes that causally increase the risk of long COVID, including 13 novel genes not previously linked to the disease.

Key Genetic Findings

  • FOX‑P4 – A variant in this gene, known for its role in immune regulation and lung function, was strongly associated with increased susceptibility.
  • 71 molecular switches that remained active a year after infection, suggesting persistent changes in gene expression.
  • 1,500+ altered gene‑expression profiles linked to immune and neurological disruption.

Implications for Clinical Practice

The discovery of these genetic markers offers a pathway toward more precise diagnostics. Clinicians can begin to stratify patients based on genetic risk, allowing for earlier intervention and tailored monitoring. Moreover, the identified biomarkers provide potential targets for therapeutic development, which could reduce the long‑term economic burden estimated at $1 trillion annually.

Actionable Steps for Health Professionals

  • Incorporate genetic screening for high‑risk patients in post‑COVID follow‑up protocols.
  • Use the identified biomarkers to monitor inflammatory and mitochondrial pathways that may drive persistent symptoms.
  • Collaborate with research teams to contribute to longitudinal studies that track genetic changes over time.

For more detailed information, read the full research papers: “Integrative Multi‑Omics Framework for Causal Gene Discovery in Long COVID” and “Omics‑Based Computational Approaches for Biomarker Identification, Prediction and Treatment of Long COVID”.

Future Directions: Expanding Data Sharing and Collaboration

The study highlights the necessity for larger, more diverse datasets and longitudinal follow‑up. International collaboration and open data platforms will accelerate the translation of these findings into clinical tools. Researchers are encouraged to participate in global consortia that focus on post‑viral syndromes.

How to Get Involved

  • Join UniSA’s research initiatives by visiting the research portal.
  • Apply for funding opportunities through the UniSA funding page.
  • Attend upcoming seminars and workshops on long COVID genetics.

Take the Next Step

Health professionals looking to integrate these insights into practice can schedule a free consultation with our health research team or submit your application today to join our research community. If you have questions or would like to share your experiences, explore our related articles for further reading and engage with the conversation in the comments below.